Credit Suisse’s Nobilis Health Corp. HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-22,040
Closed -$46K 4202
2016
Q4
$46K Sell
22,040
-777
-3% -$2.12K ﹤0.01% 4029
2016
Q3
$76K Sell
22,817
-1,676
-7% -$5.04K ﹤0.01% 3967
2016
Q2
$54K Buy
24,493
+11,648
+91% +$37.8K ﹤0.01% 4146
2016
Q1
$40K Buy
+12,845
New +$33.2K ﹤0.01% 3905
2015
Q4
Sell
-12,663
Closed -$66K 4435
2015
Q3
$66K Buy
12,663
+1,401
+12% +$8.04K ﹤0.01% 4155
2015
Q2
$77K Buy
+11,262
New +$79.9K ﹤0.01% 4417

Other funds holding HLTH

Credit Suisse's HLTH Position: Q1 2017 in Review

Credit Suisse sold out of Nobilis Health Corp. (HLTH) in Q1 2017, closing a stake of 22,040 shares — an estimated $46K sold.

Credit Suisse first reported a position in HLTH in Q2 2015 and held it in 6 quarters. The position peaked at $77K in Q2 2015. 58 funds tracked by Wall St. Rank hold HLTH as of Q1 2017.

  • Credit Suisse reported no remaining Nobilis Health Corp. position as of Q1 2017 after selling out during the quarter.
  • Credit Suisse sold 22,040 Nobilis Health Corp. shares in Q1 2017, an estimated $46K.
  • Credit Suisse first reported a position in Nobilis Health Corp. in Q2 2015 and held it in 6 quarters.
  • Credit Suisse's Nobilis Health Corp. position peaked at $77K in Q2 2015.
  • 58 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q1 2017.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.